BRD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.882100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.136000E-01
Normal-vs-Stage2
4.065900E-02
Normal-vs-Stage3
5.393900E-02
Normal-vs-Stage4
8.177800E-01
Stage1-vs-Stage2
2.868800E-01
Stage1-vs-Stage3
3.780000E-02
Stage1-vs-Stage4
3.756400E-01
Stage2-vs-Stage3
6.112100E-02
Stage2-vs-Stage4
4.916400E-02
Stage3-vs-Stage4
3.059800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.551900E-02
Normal-vs-AfricanAmerican
2.308800E-01
Normal-vs-Asian
7.839500E-02
Caucasian-vs-AfricanAmerican
9.554000E-01
Caucasian-vs-Asian
1.815350E-01
AfricanAmerican-vs-Asian
4.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.250400E-02
Normal-vs-Female
6.031900E-02
Male-vs-Female
7.873800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.217200E-01
Normal-vs-Age(41-60Yrs)
4.327200E-01
Normal-vs-Age(61-80Yrs)
5.971800E-02
Normal-vs-Age(81-100Yrs)
2.225400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.832600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.755600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.630200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.353900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.352800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.332200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.661800E-02
Normal-vs-Daily Drinker
2.144800E-01
Normal-vs-Weekly Drinker
9.836400E-02
Normal-vs-Occasional Drinker
3.266400E-01
Normal-vs-Social Drinker
3.538400E-01
Non Drinker-vs-Daily Drinker
1.098020E-01
Non Drinker-vs-Weekly Drinker
8.916800E-01
Non Drinker-vs-Occasional Drinker
7.694400E-02
Non Drinker-vs-Social Drinker
6.683800E-01
Daily Drinker-vs-Weekly Drinker
2.169800E-01
Daily Drinker-vs-Occasional Drinker
9.806800E-04
Daily Drinker-vs-Social Drinker
2.712300E-02
Weekly Drinker-vs-Occasional Drinker
1.137230E-01
Weekly Drinker-vs-Social Drinker
6.055000E-01
Occasional Drinker-vs-Social Drinker
1.794040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.766400E-02
Normal-vs-Grade 2
5.198900E-03
Normal-vs-Grade 3
1.759680E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.769800E-01
Grade 1-vs-Grade 3
6.470200E-01
Grade 1-vs-Grade 4
8.766400E-02
Grade 2-vs-Grade 3
7.627000E-01
Grade 2-vs-Grade 4
5.198900E-03
Grade 3-vs-Grade 4
1.759680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.633800E-02
Normal-vs-NonDiabetic
3.615900E-02
Diabetic-vs-NonDiabetic
5.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.530400E-01
Normal-vs-NoPancreatitis
3.929600E-02
Pancreatitis-vs-NoPancreatitis
9.921800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.360230E-01
Normal-vs-N1
4.494500E-02
N0-vs-N1
3.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.876010E-01
Normal-vs-TP53-NonMutant
2.903600E-01
TP53-Mutant-vs-TP53-NonMutant
7.238000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
